FTH: Faeth Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Caligan Partners LP | 2.40% | SEC | |
| 2026-08-14 | Fell below 5% | Trails Edge Capital Partners, LP | 2.00% | SEC | |
| 2026-08-14 | New 13G stake | Khosla Ventures VI, LP | 10.20% | SEC | |
| 2026-08-14 | Fell below 5% | StemPoint Capital LP | 0.00% | SEC |
Institutional ownership (Q2 2026)
45 institutions reported holding $333.79M of Faeth Therapeutics, Inc. on Form 13F (30 the quarter before). 22 opened a new position and 7 sold out. Shares held by institutions: +553%.
| Largest holders | Shares | Value |
|---|---|---|
| MONTANOVA CAPITAL, LLC | 2,020,103 | $50.50M |
| Avoro Capital Advisors LLC | 1,444,039 | $36.10M |
| BAKER BROS. ADVISORS LP | 1,286,411 | $32.16M |
| Balyasny Asset Management L.P. | 1,042,198 | $26.05M |
| RA CAPITAL MANAGEMENT, L.P. | 722,020 | $18.05M |
| Vivo Capital, LLC | 722,020 | $18.05M |
| Logos Global Management LP | 722,020 | $18.05M |
| Fairmount Funds Management LLC | 722,020 | $18.05M |
| Caligan Partners LP | 629,467 | $15.74M |
| B Group, Inc. | 610,169 | $15.25M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.